CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Brazil

Publisher Name:
Published Date: 14-Oct-2013
No. of pages: 320

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape Brazil”. This report is an essential source of information and analysis regarding the healthcare, regulatory and reimbursement landscape in Brazil. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

In 2012, Brazil’s population amounted to an estimated 198.4 million. The population is increasing steadily, which is largely due to a positive balance between the birth rate and the mortality rate. The country currently has a demographic advantage in terms of a large working age population, which increased in size from 2007 to 2012. The size of the elderly population aged 65 years and older is expected to increase in future to account for more than 9% of the population by 2020. The value of Brazil’s pharmaceutical market amounted to an estimated $23.8 billion in 2012 and is expected to have reached approximately $58.8 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 12%. The value of the medical device market amounted to approximately $7.9 billion in 2012 and is expected to reach approximately $13.1 billion in 2020 at a projected CAGR of 6.5%. These positive trends can primarily be attributed to -

  • An increasing elderly population
  • Healthcare coverage for 60-80% of the Brazilian population

 

Scope

  • The report provides information on the healthcare, regulatory, and reimbursement landscape in Brazil, and includes -
  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market (Pfizer Inc., Sanofi, Novartis and F. Hoffmann-La Roche Ltd. and AstraZeneca) and the medical device market (Siemens Healthcare, GE Healthcare, F. Hoffmann-La Roche, Essilor International, and Philips Healthcare)
  • Insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, regulatory agencies, and approval processes for new drugs and medical devices
  • Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges facing growth in the Brazilian healthcare market

Reasons to buy

  • This report will enhance your decision-making capability by allowing you to -
  • Develop business strategies by understanding the trends shaping and driving Brazil’s healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
  • Identify, understand, and capitalize on the opportunities and challenges in Brazil’s healthcare market.

Table of Contents For This Report

Table of Contents

1 Table of Contents 6

1.1 List of Tables 9

1.2 List of Figures 14

2 Introduction 19

2.1 GlobalData Report Guidance 19

3 Overview of the Pharmaceutical and Medical Devices Market 20

3.1 Pharmaceutical Market 20

3.1.1 Market Overview 20

3.1.2 Pharmaceutical Import and Export 23

3.1.3 Supply Channels 24

3.1.4 Market Segments 27

3.1.5 Major Disease Areas 32

3.1.6 Major Players 38

3.2 Medical Device Market 84

3.2.1 Market Overview 84

3.2.2 Overview of Leading Five Segments 87

3.2.3 Diagnostic Market 103

3.2.4 Major Players 105

3.3 Market Drivers and Barriers 138

3.3.1 Drivers 138

3.3.2 Barriers 139

4 Market Access 142

4.1 Overview of Healthcare System 142

4.1.1 Organizational structure 142

4.2 Reimbursement and Payer Landscape 145

4.2.1 Reimbursement Process 147

4.2.2 Pricing Procedure 150

4.2.3 Overview of Insurance Providers 153

4.2.4 Patient Share in Healthcare Spending 160

4.2.5 Drug Price Trend 161

4.2.6 Pricing Policies 162

4.3 Regulatory Landscape 164

4.3.1 Overview of Regulatory Agencies 164

4.3.2 New Drug Approval Process 172

4.3.3 Generic Drug Approval Process 176

4.3.4 New Medical Device Approval Process 179

4.3.5 Licensing Process for Pharmaceutical and Medical Device Manufacturing 183

4.3.6 Licensing Process for Pharmaceutical Exports and Imports 184

4.3.7 Intellectual Property Rights 186

4.3.8 Clinical Trial Regulations 191

4.3.9 Pharmaceutical Advertising Regulations 193

4.3.10 Pharmacy Regulations 193

4.3.11 Labeling and Packaging Regulations 195

5 Country Analysis 197

5.1 Political Environment 197

5.1.1 Political Structure 197

5.1.2 Analysis of Current Political Environment 198

5.1.3 Healthcare Policy Initiatives 200

5.2 Economic Landscape 206

5.3 Economic Indicators 211

5.3.1 Gross Domestic Product 211

5.3.2 Gross National Income 216

5.3.3 Inflation 217

5.3.4 Currency Exchange Rate 220

5.3.5 Foreign Direct Investment 221

5.3.6 Foreign Exchange Reserves 222

5.3.7 Trade Balance 223

5.3.8 Government Structural Balance 226

5.3.9 Government Net Debt 227

5.3.10 Major Industries 228

5.4 Demography 230

5.4.1 Population 230

5.4.2 Education and Literacy 247

5.4.3 Employment 249

5.4.4 Disease Burden 250

5.5 Healthcare Infrastructure 253

5.5.1 Healthcare Facilities 254

5.5.2 Healthcare Parameters 261

5.5.3 Environmental Health 263

5.5.4 Healthcare Personnel 271

5.6 Healthcare Expenditure 273

5.6.1 Overview 273

5.6.2 Major Components of Healthcare Spending 274

5.6.3 Share of Public and Private Sectors 277

5.6.4 Spending on Pharmaceutical R&D 278

5.7 Trade Associations 279

5.7.1 ABIMO 279

5.7.2 ABIMED 279

5.7.3 Interfarma 280

5.7.4 Abiquifi 280

5.8 Trade Fairs 281

6 Opportunities and Challenges 282

6.1 Opportunities 282

6.2 Challenges 283

7 Appendix 285

7.1 Abbreviations 285

7.2 Bibliography 298

7.3 Methodology 317

7.3.1 Coverage 317

7.3.2 Secondary Research 318

7.3.3 Forecasting 318

7.3.4 Expert Panel Validation 318

7.4 Disclaimer 319

List of Tables

Table 1: Pharmaceutical Industry, Brazil, Revenue ($bn), 2007-2012 21

Table 2: Pharmaceutical Market, Brazil, Revenue ($bn), Forecast, 2013-2020 22

Table 3: Pharmaceutical Market, Brazil, Exports and Imports ($bn), 2007-2012 23

Table 4: Pharmaceutical Market, Brazil, Margin of Preference For Drugs And Medications, 2013 26

Table 5: Pharmaceutical Market, Brazil, Product Development Partnerships of Biologics, 2013 30

Table 6: Pharmaceutical Market, Brazil, Proportional Distribution of Types of Cancer by Incidence, 2012 33

Table 7: Pharmaceutical Market, Brazil, Mortality by Type of Cancer (%), 2010 34

Table 8: Pharmaceutical Market, Brazil, Mortality by Major Disease Areas (%), 2010 37

Table 9: Pfizer, Global, Major Products, Revenue ($m), 2012 39

Table 10: Pfizer, Global, Late-stage Pipeline, 2013 39

Table 11: Novartis, Global, Major Products, Revenue ($m), 2012 50

Table 12: Novartis, Global, Planned Filings, 2012-2016 51

Table 13: Sanofi, Global, Major Products, Revenue ($bn), 2012 58

Table 14: Sanofi, Global, Late-stage Pipeline, 2013 59

Table 15: Roche, Global, Major Products, Revenue ($bn), 2012 65

Table 16: Roche, Global, Late-stage Pipeline, 2013 66

Table 17: AstraZeneca, Global, Major Products, Revenue ($bn), 2011 73

Table 18: AstraZeneca, Global, Late-stage Pipeline, 2012 74

Table 19: Medical Device Market, Brazil, Revenue ($bn), 2007-2012 85

Table 20: Medical Device Market, Brazil, Revenue Forecast ($bn), 2013-2020 86

Table 21: Medical Device Market, Brazil, Revenue by Segment ($bn), 2012 87

Table 22: Medical Device Market, Brazil, Ophthalmic Devices Market, Revenue ($bn), 2007-2012 89

Table 23: Medical Device Market, Brazil, Sales Trend for Major Players*, Ophthalmic Devices, 2011 90

Table 24: Medical Device Market, Brazil, In-Vitro Diagnostics Market, Revenue ($bn), 2007-2012 92

Table 25: Medical Device Market, Brazil, Sales Trend for Major Players*, In-Vitro Diagnostic Devices, 2011 93

Table 26: Medical Device Market, Brazil, Diagnostic Imaging Market, Revenue ($bn), 2007-2012 95

Table 27: Medical Device Market, Brazil, Sales Trends for Major Players*, Diagnostic Imaging Devices, 2011 96

Table 28: Medical Device Market, Brazil, Orthopedic Devices Market, Revenue ($bn), 2007-2012 98

Table 29: Medical Device Market, Brazil, Sales Trend for Major Players*, Orthopedic Devices, 2011 99

Table 30: Medical Device Market, Brazil, Cardiovascular Devices Market, Revenue ($bn), 2007-2012 101

Table 31: Medical Device Market, Brazil, Sales Trend for Major Players*, Cardiovascular Devices, 2011 102

Table 32: Medical Device Market, Brazil, Diagnostics Market, Revenue ($bn), 2007-2012 103

Table 33: Medical Device Market, Brazil, Diagnostics Market, Revenue ($bn), Forecast, 2013-2020 104

Table 34: Medical Device Market, Brazil, Major Medical Device Companies, Revenue ($m), 2011 105

Table 35: Siemens, Global, Major Products, Revenue ($m), 2012 106

Table 36: Roche, Global, Major Products, Revenue ($m), 2012 118

Table 37: Essilor International, Global, Major Segments, Revenue ($m), 2011 125

Table 38: Philips Healthcare, Global, Major Products, Revenue ($bn), 2012 131

Table 39: Healthcare System, Brazil, 2013 142

Table 40: Healthcare System, Brazil, Comparative Analysis of CITEC and CONITEC, 2013 148

Table 41: Healthcare System, Brazil, Mean Reduction in Factory Price and Number of Products (%), 2004-2011 153

Table 42: Healthcare Spending, Brazil, Decision-Making Structure of SUS, 2013 155

Table 43: Healthcare Spending, Brazil, Distribution of Health Insurance Beneficiaries (%), 2013 156

Table 44: Healthcare Spending, Brazil, Private Health Insurance Beneficiaries (million), 2007-2012 157

Table 45: Healthcare Spending, Brazil, Out-of-Pocket Expenditure (%), 2007-2012 160

Table 46: Price of Drugs, Brazil, Change in Average Price of Prescription (%), 2007-2011 161

Table 47: Pricing Policies, Brazil, 2013 163

Table 48: Healthcare System, Brazil, Documents Required for Dossier Submission of Clinical Trial, 2013 192

Table 49: Economic Landscape, Brazil, BRICS Comparison, 2012 208

Table 50: Economic Indicators, Brazil, Gross Domestic Product Per Capita ($), 2007-2012 212

Table 51: Economic Indicators, Brazil, Gross Domestic Product Per Capita ($), Forecast, 2013-2020 212

Table 52: Economic Indicators, Brazil, Gross Domestic Product Annual Growth (%), 2007-2012 213

Table 53: Economic Indicators, Brazil, Gross Domestic Product Annual Growth (%), Forecast, 2013-2020 214

Table 54: Economic Indicators, Brazil, Gross Domestic Product, Brazil, Russia, India, China, Annual Growth (%), 2007-2012 215

Table 55: Economic Indicators, Brazil, Gross National Income Per Capita ($), 2007-2012 216

Table 56: Economic Indicators, Brazil, Average Consumer Price Index, 2007-2012 218

Table 57: Economic Indicators, Brazil, Average Consumer Price Annual Change (%), 2007-2012 219

Table 58: Economic Indicators, Brazil, Currency Exchange Rate ($/BRL), 2007-2012 220

Table 59: Economic Indicators, Brazil, Foreign Direct Investment ($bn), 2007-2012 221

Table 60: Economic Indicators, Brazil, Foreign Exchange Reserves ($bn), 2007-2012 222

Table 61: Economic Indicators, Brazil, Trade Balance ($bn), 2007-2012 223

Table 62: Economic Indicators, Brazil, Imports of Goods and Services ($bn), 2007-2012 224

Table 63: Economic Indicators, Brazil, Exports of Goods and Services ($bn), 2007-2012 225

Table 64: Economic Indicators, Brazil, General Government Structural Balance ($bn), 2007-2012 226

Table 65: Economic Indicators, Brazil, General Government Net Debt ($bn), 2007-2012 227

Table 66: Economic Indicators, Brazil, Major Industries by Contribution to GDP (%), 2011 229

Table 67: Demographics, Brazil, Population (million), 2007-2012 230

Table 68: Demographics, Brazil, Population (million), Forecast, 2013-2020 231

Table 69: Demographics, Brazil, Urban and Rural Population Share (%), 2007-2012 233

Table 70: Demographics, Brazil, Urban and Rural Population Share (%), Forecast, 2013-2020 234

Table 71: Demographics, Brazil, Population Distribution by Age Group (%), 2007-2012 236

Table 72: Demographics, Brazil, Population Distribution by Age Group (%), Forecast, 2013-2020 236

Table 73: Demographics, Brazil, (Per 1,000 Population), 2007-2012 238

Table 74: Demographics, Brazil, Mortality (Per 1,000 Population), 2007-2012 238

Table 75: Demographics, Brazil, Major Causes of Mortality (‘000), 2010 240

Table 76: Demographics, Brazil, Children Table 77: Demographics, Brazil, Immunization Rate (%), 2007-2012 242

Table 78: Demographics, Brazil, Major Causes of Mortality per 100,000 Population, 2010 244

Table 79: Demographics, Brazil, Gender Ratio (M/F), 2007-2012 245

Table 80: Demographics, Brazil, Life Expectancy at Birth (Years), 2007-2012 246

Table 81: Demographics, Brazil, Illiteracy (%), 2007-2012 248

Table 82: Demographics, Brazil, Employment Rate (%), 2007-2012 250

Table 83: Demographics, Brazil, Major Diseases, DALY (Per 100,000 Population), 2004 251

Table 84: Demographics, Brazil, Major Diseases, In Patients, Jan 2013-May 2013 252

Table 85: Healthcare Infrastructure, Brazil, Total Number of Hospitals, 2012 254

Table 86: Healthcare Infrastructure, Brazil, Hospitals Linked to SUS (%), 2013 255

Table 87: Healthcare Infrastructure, Brazil, Hospital Beds (‘000), 2012 256

Table 88: Healthcare Infrastructure, Brazil, Hospital Beds by Type of Service (‘000), 2013 256

Table 89: Healthcare Infrastructure, Brazil, Hospitals Beds by Type of Care (‘000), 2012 257

Table 90: Healthcare Infrastructure, Brazil, SUS ICU Beds by Type, 2013 258

Table 91: Healthcare Infrastructure, Brazil, Complementary Services (‘000), 2013 259

Table 92: Healthcare Infrastructure, Brazil, Number of Items of Equipment (‘000), 2013 260

Table 93: Healthcare Infrastructure, Brazil, Beds (Per 1,000 Population), 2007-2012 261

Table 94: Healthcare Infrastructure, Brazil, Physicians (per 1,000 Population), 2007-2012 262

Table 95: Environmental Health, Brazil, Targets for Carbon Reduction, 2009 264

Table 96: Environmental Health, Brazil, PM10 Emissions (?g/m3), 2007-2012 265

Table 97: Environmental Health, Brazil, N2O Emissions (’000 metric tons), 2007-2012 266

Table 98: Environmental Health, Brazil, CO2 Emissions (kilotons), 2007-2012 267

Table 99: Environmental Health, Brazil, Other Greenhouse Gas Emissions (‘000 metric tons), 2007-2012 269

Table 100: Environmental Health, Brazil, Proportion of the Population Using Improved Drinking Water Sources (%), 2007-2012 270

Table 101: Healthcare Personnel, Brazil, Healthcare Personnel (’000), 2013 272

Table 102: Healthcare Expenditure, Brazil, Healthcare Expenditure (% of GDP), 2007-2012 273

Table 103: Healthcare Expenditure, Brazil, Household Healthcare Expenditure, Share (%), 2009 275

Table 104: Healthcare Expenditure, Brazil, General Government Healthcare Expenditure, Share (%), 2009 276

Table 105: Healthcare Expenditure, Brazil, Health Expenditure, Public-Private Share (%), 2007-2012 277

Table 106: Healthcare Expenditure, Brazil, Pharmaceutical R&D Expenditure, Share (%), 2008 278

Table 107: Healthcare Expenditure, Brazil, Biopharmaceutical R&D Financing in China, India, Brazil and South Africa, 2013 279

Table 108: Major Healthcare Trade Fairs, Brazil, 2013 281

List of Figures

Figure 1: Pharmaceutical Industry, Brazil, Revenue ($bn), 2007-2012 21

Figure 2: Pharmaceutical Market, Brazil, Revenue ($bn), Forecast, 2013-2020 22

Figure 3: Pharmaceutical Market, Brazil, Exports and Imports ($bn), 2007-2012 23

Figure 4: Pharmaceutical Market, Brazil, Pharmaceutical Distribution Channel, 2013 25

Figure 5: Pharmaceutical Market, Brazil, Mortality by Type of Cancer (%), 2010 34

Figure 6: Pharmaceutical Market, Brazil, Mortality by Major Disease Areas (%), 2010 37

Figure 7: Medical Device Market, Brazil, Revenue ($bn), 2007-2012 85

Figure 8: Medical Device Market, Brazil, Revenue Forecast ($bn), 2013-2020 86

Figure 9: Medical Device Market, Brazil, Revenue by Segment ($bn), 2012 87

Figure 10: Medical Device Market, Brazil, Ophthalmic Devices Market, Revenue ($bn), 2007-2012 89

Figure 11: Medical Device Market, Brazil, Sales Trends for Major Players*, Ophthalmic Devices, 2007-2011 90

Figure 12: Medical Device Market, Brazil, In-Vitro Diagnostics Market, Revenue ($bn), 2007-2012 92

Figure 13: Medical Device Market, Brazil, Sales Trend for Major Players*, In-Vitro Diagnostic Devices, 2007-2011 93

Figure 14: Medical Device Market, Brazil, Diagnostic Imaging Market, Revenue ($bn), 2007-2012 95

Figure 15: Medical Device Market, Brazil, Sales Trends for Major Players*, Diagnostic Imaging Devices, 2007-2011 96

Figure 16: Medical Device Market, Brazil, Orthopedic Devices Market, Revenue ($bn), 2007-2012 98

Figure 17: Medical Device Market, Brazil, Sales Trend for Major Players*, Orthopedic Devices, 2007-2011 99

Figure 18: Medical Device Market, Brazil, Cardiovascular Devices Market, Revenue ($bn), 2007-2012 101

Figure 19: Medical Device Market, Brazil, Sales Trend for Major Players*, Cardiovascular Devices, 2007-2011 102

Figure 20: Medical Device Market, Brazil, Diagnostics Market, Revenue ($bn), 2007-2012 103

Figure 21: Medical Device Market, Brazil, Diagnostics Market, Revenue ($bn), Forecast, 2013-2020 104

Figure 22: Medical Device Market, Brazil, Major Medical Device Companies, Revenue ($m), 2011 105

Figure 23: Healthcare Market, Brazil, Drivers and Barriers, 2013 141

Figure 24: Healthcare System, Brazil, Financing Flows, 2013 144

Figure 25: Healthcare System, Brazil, Reimbursement System, 2013 147

Figure 26: Healthcare System, Brazil, Reimbursement Process, 2013 150

Figure 27: Healthcare System, Brazil, Flowchart for Classification of Drugs into Categories, 2013 152

Figure 28: Healthcare Spending, Brazil, Health Insurance Providers, 2013 154

Figure 29: Healthcare Spending, Brazil, Distribution of Health Insurance Beneficiaries (%), 2013 155

Figure 30: Healthcare Spending, Brazil, Private Health Insurance Beneficiaries (million), 2007-2012 156

Figure 31: Healthcare System, Brazil, Organization Structure of ANS, 2013 158

Figure 32: Healthcare Spending, Brazil, Out-of-Pocket Expenditure (%), 2007-2012 160

Figure 33: Price of Drugs, Brazil, Change in Average Price of Drugs (%), 2007-2011 161

Figure 34: Healthcare System, Brazil, Ministry of Health Organizational Structure, 2013 166

Figure 35: Healthcare System, Brazil, ANVISA Old Organizational Structure, 2013 168

Figure 36: Healthcare System, Brazil, Roles and Responsibilities of Regulatory Bodies, 2013 172

Figure 37: Healthcare System, Brazil, New Drug Approval Stages, 2013 173

Figure 38: Healthcare System, Brazil, New Drug Approval Process, 2013 175

Figure 39: Healthcare System, Brazil, Generic Drug Approval Process, 2013 177

Figure 40: Healthcare System, Brazil, Similar Drug (Biosimilar) Approval Process, 2013 178

Figure 41: Healthcare System, Brazil, New Medical Device Approval Process, 2013 180

Figure 42: Economic Indicators, Brazil, Gross Domestic Product Per Capita ($), 2007-2012 211

Figure 43: Economic Indicators, Brazil, Gross Domestic Product Per Capita ($), Forecast, 2013-2020 212

Figure 44: Economic Indicators, Brazil, Gross Domestic Product Annual Growth (%), 2007-2012 213

Figure 45: Economic Indicators, Brazil, Gross Domestic Product Annual Growth (%), Forecast, 2013-2020 214

Figure 46: Economic Indicators, Brazil, Gross National Income Per Capita ($), 2007-2012 216

Figure 47: Economic Indicators, Brazil, Average Consumer Price Index, 2007-2012 218

Figure 48: Economic Indicators, Brazil, Average Consumer Price Annual Change (%), 2007-2012 219

Figure 49: Economic Indicators, Brazil, Currency Exchange Rate ($/BRL), 2007-2012 220

Figure 50: Economic Indicators, Brazil, Foreign Direct Investment ($bn), 2007-2012 221

Figure 51: Economic Indicators, Brazil, Foreign Exchange Reserves ($bn), 2007-2012 222

Figure 52: Economic Indicators, Brazil, Trade Balance ($bn), 2007-2012 223

Figure 53: Economic Indicators, Brazil, Imports of Goods and Services ($bn), 2007-2012 224

Figure 54: Economic Indicators, Brazil, Exports of Goods and Services ($bn), 2007-2012 225

Figure 55: Economic Indicators, Brazil, General Government Structural Balance ($bn), 2007-2012 226

Figure 56: Economic Indicators, Brazil, General Government Net Debt ($bn), 2007-2012 227

Figure 57: Economic Indicators, Brazil, Major Industries by % Contribution to GDP, 2011 228

Figure 58: Demographics, Brazil, Population (million), 2007-2012 230

Figure 59: Demographics, Brazil, Population (million), Forecast, 2013-2020 231

Figure 60: Demographics, Brazil, Urban and Rural Population Share (%), 2007-2012 233

Figure 61: Demographics, Brazil, Urban and Rural Population Share (%), Forecast, 2013-2020 234

Figure 62: Demographics, Brazil, Population Distribution by Age Group (%), 2007-2012 235

Figure 63: Demographics, Brazil, Population Distribution by Age Group (%), Forecast, 2013-2020 236

Figure 64: Demographics, Brazil, Births (Per 1,000 Population), 2007-2012 237

Figure 65: Demographics, Brazil, Mortality (Per 1,000 Population), 2007-2012 238

Figure 66: Demographics, Brazil, Major Causes of Mortality (‘000), 2010 239

Figure 67: Demographics, Brazil, Children Figure 68: Demographics, Brazil, Immunization Rate (%), 2007-2012 242

Figure 69: Demographics, Brazil, Major Causes of Mortality per 100,000 Population, 2010 243

Figure 70: Demographics, Brazil, Gender Ratio (M/F), 2007-2012 245

Figure 71: Demographics, Brazil, Life Expectancy at Birth (Years), 2007-2012 246

Figure 72: Demographics, Brazil, Illiteracy (%), 2007-2012 248

Figure 73: Demographics, Brazil, Employment Rate (%), 2007-2012 249

Figure 74: Demographics, Brazil, Major Diseases, DALY (Per 100,000 Population), 2004 250

Figure 75: Healthcare Infrastructure, Brazil, Flow of Funds to Hospitals, 2008 253

Figure 76: Healthcare Infrastructure, Brazil, Hospitals Linked to SUS (%), 2013 254

Figure 77: Healthcare Infrastructure, Brazil, Hospital Beds (‘000), 2007-2012 255

Figure 78: Healthcare Infrastructure, Brazil, Hospital Beds by Type of Service (‘000), 2013 256

Figure 79: Healthcare Infrastructure, Brazil, Hospitals Beds by Type of Care (‘000), 2012 257

Figure 80: Healthcare Infrastructure, Brazil, SUS ICU Beds by Type, 2013 258

Figure 81: Healthcare Infrastructure, Brazil, Complementary Services (‘000), 2013 259

Figure 82: Healthcare Infrastructure, Brazil, Number of Items of Equipment (‘000), 2013 260

Figure 83: Healthcare Infrastructure, Brazil, Beds (Per 1,000 Population), 2007-2012 261

Figure 84: Healthcare Infrastructure, Brazil, Physicians (per 1,000 Population), 2007-2012 262

Figure 85: Environmental Health, Brazil, PM10 Emissions (?g/m3), 2007-2012 265

Figure 86: Environmental Health, Brazil, N2O Emissions (‘000 metric tons), 2007-2012 266

Figure 87: Environmental Health, Brazil, CO2Emissions (kilotons), 2007-2012 267

Figure 88: Environmental Health, Brazil, Other Greenhouse Gas Emissions (‘000 metric tons), 2007-2012 269

Figure 89: Environmental Health, Brazil, Proportion of the Population Using Improved Drinking Water Sources (%), 2007-2012 270

Figure 90: Healthcare Personnel, Brazil, Healthcare Personnel (’000), 2013 271

Figure 91: Healthcare Expenditure, Brazil, Healthcare Expenditure (% of GDP), 2007-2012 273

Figure 92: Healthcare Expenditure, Brazil, Household Healthcare Expenditure, Share (%), 2009 274

Figure 93: Healthcare Expenditure, Brazil, General Government Healthcare Expenditure, Share (%), 2009 276

Figure 94: Healthcare Expenditure, Brazil, Health Expenditure, Public-Private Share (%), 2007-2012 277

Figure 95: Healthcare Expenditure, Brazil, Pharmaceutical R&D Expenditure, Components Share (%), 2008 278

Figure 96: Healthcare Market, Brazil, Opportunities and Challenges, 2013 284

Get Updates

Share This Post

Latest Reports from Life Sciences category

© 2014 MarketOptimizer.org. All rights reserved.